CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
July 12, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has...
Integrity Implants and Fusion Robotics Merge to Form Accelus
July 06, 2021 13:00 ET
|
Integrity Implants Inc.
PALM BEACH GARDENS, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- Integrity Implants Inc., a privately held medical device company focused on Adaptive Geometry™ technology designed to enable MIS spine...
Minimally Invasive & Non-Invasive Medical Imaging Market to Touch USD 88.88 Billion by 2027; High Demand for Real Time Image Processing with High-Quality Images for Efficient Results to Create Opportunities for Market Growth Over 2020-2027
November 26, 2020 07:28 ET
|
Research Nester
New York, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The number of robotic surgeries skyrocketed in the last decade. With the success rate ranging between 90-100%, a significant increase in the minimally...
CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer
November 17, 2020 05:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada,...
CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
November 04, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...
CLS Conducts In-Vivo Laser Ablation Studies for Neuro and Prostate using TRANBERG Thermal Therapy System with Thermoguide
May 22, 2020 04:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, May 22, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it is conducting new in-vivo precision laser ablation treatment...
CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator
April 29, 2020 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, April 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it was granted a new U.S. Patent valid until 2036 covering its...
SPR Therapeutics Announces 1000th Sprint PNS Procedure
December 04, 2019 08:30 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market to Witness a CAGR of 39.1% during 2018-2024: Energias Market Research Pvt. Ltd.
April 09, 2018 08:13 ET
|
Energias Market Research
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- The global minimally invasive glaucoma surgery (MIGS) devices market is expected to witness a CAGR of 39.1%, and is projected to reach USD 2392.5 million...
Minimally Invasive Surgical Instruments Market to Touch US$ 18,900 Mn by 2022 – Persistence Market Research
October 16, 2017 06:15 ET
|
Persistence Market Research
New York, Oct. 16, 2017 (GLOBE NEWSWIRE) -- In the minimally invasive surgeries, small incisions are made on the body. A laparoscope is inserted through one of the incisions or openings to serve as...